Mette Ølgod Pedersen

Mette Ølgod Pedersen is a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Pathology. She is affiliated with the Department of Pathology at Copenhagen University Hospital in Copenhagen.

Her research focuses on hematological malignancies, particularly lymphoma and Waldenström macroglobulinemia. Dr. Pedersen's work examines biomarkers, mutational landscapes, and prognostic factors in these conditions, with a strong emphasis on clinical applications and patient outcomes. Her research has identified important patterns in central nervous system involvement, extramedullary disease, and nodal involvement in Waldenström macroglobulinemia. She has also investigated inflammatory signatures and protein biomarkers that predict survival in aggressive B-cell lymphomas, with important implications for understanding tumor microenvironments and potential immunotherapy approaches.

Dr. Pedersen's scientific contributions span from 2019 to 2025, with recent publications appearing in high-impact hematology journals including HemaSphere, Annals of Hematology, British Journal of Haematology, and Hematological Oncology. Her work has been cited in Scopus and garnered attention from multiple news outlets and social media platforms including X (formerly Twitter) and Bluesky.

She maintains extensive collaborations with researchers across Denmark, particularly with Lise Mette Rahbek Gjerdrum, Søren Østergaard, and other hematologists, focusing on population-based studies of rare hematological conditions to improve clinical understanding and patient management.